Evidence map›Paper›PMID 40489825›Full record

ArticleMedicine2025

Invasive pulmonary aspergillosis often misdiagnosed as lung cancer: A case report.

Ruiping Bu, Yanhong Zong, Jianping Xu, Jing Yang, Chenda Zhai

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruiping BuDepartment of Internal Medicine, Graduate School of Hebei Medical University, Shijiazhuang, Hebei, China.ORCID 0009-0003-1501-638
Yanhong ZongDepartment of Laboratory Medicine, Hebei General Hospital, Shijiazhuang, Hebei, China.
Jianping XuDepartment of Infectious Diseases, Hebei General Hospital, Shijiazhuang, Hebei, China.
Jing YangDepartment of Infectious Diseases, Hebei General Hospital, Shijiazhuang, Hebei, China.ORCID 0009-0005-9229-5559
Chenda ZhaiDepartment of Infectious Diseases, Hebei General Hospital, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleThe incidence of epidemiological pulmonary aspergillosis (PA) is increasing worldwide. Diagnosis of PA is challenging because of the nonspecificity of its clinical manifestations and imaging characteristics. PA has a high mortality rate, making early diagnosis and treatment critical. PATIENT CONCERNS: A 67-year-old female patient was admitted to the hospital with a half-month history of cough, blood-tinged sputum, and a sore throat. The patient had no history of chronic diseases, such as hypertension, coronary heart disease, or diabetes. The patient had a family history of cancer. DIAGNOSES: The patient was diagnosed with invasive pulmonary aspergillosis (IPA).

interventionsAfter the diagnosis of IPA, the patient underwent antifungal treatment with oral voriconazole. OUTCOMES: After treatment, the patient's symptoms improved, and a follow-up chest computed tomography scan showed a reduction in the area of inflammation. LESSONS: Immunocompetent individuals may develop IPA. The clinical and imaging manifestations of IPA vary, which makes misdiagnosis possible. When necessary, a pathological biopsy can be performed to confirm the diagnosis.

Indexed as

Diagnostic ErrorsInvasive Pulmonary AspergillosisLung NeoplasmsAgedAntifungal AgentsDiagnosis, DifferentialFemaleHumansTomography, X-Ray ComputedVoriconazoleAntifungal AgentsVoriconazoleinvasive pulmonary aspergilluslung cancernonimmunocompromised host

Identifiers

PMID40489825
PMCPMC12151011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.